Bicycle Therapeutics (BCYC) Shares Issued (2018 - 2026)

Bicycle Therapeutics' Shares Issued history runs 9 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• Quarterly Shares Issued rose 247.21% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (up 247.21% YoY) and the FY2025 annual result came in at $9.8 million, up 12.05% from the prior year.
• Shares Issued was $1.7 million for Q1 2026 at Bicycle Therapeutics, down from $9.8 million in the prior quarter.
• Across five years, Shares Issued topped out at $10.2 million in Q3 2025 and bottomed at $100700.0 in Q3 2024.
• A 5-year average of $5.1 million and a median of $5.9 million in 2022 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2024 — Shares Issued tumbled 98.62% — and 2025, when it jumped 10018.96%.
• Bicycle Therapeutics' Shares Issued stood at $5.9 million in 2022, then gained by 26.63% to $7.5 million in 2023, then rose by 17.13% to $8.7 million in 2024, then grew by 12.05% to $9.8 million in 2025, then slumped by 82.74% to $1.7 million in 2026.
• Business Quant data shows BCYC's Shares Issued at $1.7 million in Q1 2026, $9.8 million in Q4 2025, and $10.2 million in Q3 2025.